Publications

Background from the REBORNE Project

  • Cordonnier, T., A. Langonné, et al. (2010). “Consistent osteoblastic differentiation of human mesenchymal stem cells with bone morphogenetic protein 4 and low serum.” Tissue Engineering Part C: Methods 17(3): 249-259.
  • Parazzi, V., L. Lazzari, et al. (2010). “Platelet gel from cord blood: a novel tool for tissue engineering.” Platelets 21(7): 549-554.
  • Rebulla, P., T. Montemurro, et al. (2010). “Regulation of cell‐based medicine: the European experience.” ISBT Science Series 5(n1): 249-251. PDF
  • Cassatella, M. A., F. Mosna, et al. (2011). “Toll‐Like Receptor‐3‐Activated Human Mesenchymal Stromal Cells Significantly Prolong the Survival and Function of Neutrophils.” Stem Cells 29(6): 1001-1011. PDF
  • Cordonnier, T., J. Sohier, et al. (2011). “Biomimetic materials for bone tissue engineering–state of the art and future trends.” Advanced Engineering Materials 13(5): B135-B150.
  • Lavenus, S., M. Berreur, et al. (2011). “Adhesion and osteogenic differentiation of human mesenchymal stem cells on titanium nanopores.” Eur Cell Mater 22(84): e96. PDF
  • Ménard, C. and K. Tarte (2011). “Immunosuppression et cellules souches mésenchymateuses-Mieux comprendre une propriété thérapeutique majeure.” médecine/sciences 27(3): 269-274. PDF
  • Schmidtke-Schrezenmeier, G., M. Urban, et al. (2011). “Labeling of mesenchymal stromal cells with iron oxide–poly (L-lactide) nanoparticles for magnetic resonance imaging: uptake, persistence, effects on cellular function and magnetic resonance imaging properties.” Cytotherapy 13(8): 962-975. PDF
  • Sensebé, L. and P. Bourin (2011). “Cellules souches mésenchymateuses-Production à usage clinique et contraintes sécuritaires.” médecine/sciences 27(3): 297-302. PDF
  • Bouacida, A., P. Rosset, et al. (2012). “Pericyte-like progenitors show high immaturity and engraftment potential as compared with mesenchymal stem cells.” PLoS One 7(11): e48648. PDF
  • Coquelin, L., A. Fialaire-Legendre, et al. (2012). “In vivo and in vitro comparison of three different allografts vitalized with human mesenchymal stromal cells.” Tissue Engineering Part A 18(17-18): 1921-1931.
  • Fekete, N., M. T. Rojewski, et al. (2012). “GMP-compliant isolation and large-scale expansion of bone marrow-derived MSC.” PLoS One 7(8): e43255. PDF
  • Perez, R. A., H.-W. Kim, et al. (2012). “Polymeric additives to enhance the functional properties of calcium phosphate cements.” Journal of tissue engineering 3(1): 2041731412439555. PDF
  • Rebulla, P. and R. Giordano (2012). “Role of the blood service in cellular therapy.” Biologicals 40(3): 218-221.
  • Siniscalco, D., A. Giordano, et al. (2012). “Novel insights in basic and applied stem cell therapy.” Journal of cellular physiology 227(5): 2283-2286.
  • Vernikouskaya, I., P. Bernhardt, et al. (2012). “T2 relaxation time mapping in phantom and in vivo myocardial studies to investigate optimal method of quantification.” Journal of Cardiovascular Magnetic Resonance 14(1): P287. PDF
  • Belingheri, M., L. Lazzari, et al. (2013). “Allogeneic mesenchymal stem cell infusion for the stabilization of focal segmental glomerulosclerosis.” Biologicals 41(6): 439-445.
  • Bouderlique, T. (2013). Etude des propriétés ostéoinductrices et chondroinductrices de” l’Heparin affin regulatory peptide” sur les cellules stromales mésenchymateuses humaines, application en régénération osseuse, Université Paris-Est Créteil.
  • Corselli, M., C. J. Chin, et al. (2013). “Perivascular support of human hematopoietic stem/progenitor cells.” Blood 121(15): 2891-2901.
  • Daculsi, G., B. Fellah, et al. (2013). “Osteoconduction, Osteogenicity, Osteoinduction, what are the fundamental properties for a smart bone substitutes.” IRBM 34(4): 346-348.
  • Daculsi, G., T. Miramond, et al. (2013). Smart calcium phosphate bioceramic scaffold for bone tissue engineering. Key Engineering Materials, Trans Tech Publications. PDF
  • Deschaseaux, F., J. Gaillard, et al. (2013). “Regulation and function of immunosuppressive molecule human leukocyte antigen G5 in human bone tissue.” The FASEB Journal 27(8): 2977-2987.
  • Di Trapani, M., G. Bassi, et al. (2013). “Comparative study of immune regulatory properties of stem cells derived from different tissues.” Stem cells and development 22(22): 2990-3002.
  • Menard, C., L. Pacelli, et al. (2013). “Clinical-grade mesenchymal stromal cells produced under various GMP processes differ in their immunomodulatory properties: Standardization of immune quality controls.” Stem Cells Dev 22(12): 1789-1801.
  • Menard, C., L. Pacelli, et al. (2013). “Clinical-grade mesenchymal stromal cells produced under various good manufacturing practice processes differ in their immunomodulatory properties: standardization of immune quality controls.” Stem cells and development 22(12): 1789-1801.
  • Ménard, C. and K. Tarte (2013). “Immunoregulatory properties of clinical grade mesenchymal stromal cells: evidence, uncertainties, and clinical application.” Stem cell research & therapy 4(3): 64.
  • Mietsch, A., C. Neidlinger‐Wilke, et al. (2013). “Evaluation of platelet‐rich plasma and hydrostatic pressure regarding cell differentiation in nucleus pulposus tissue engineering.” Journal of tissue engineering and regenerative medicine 7(3): 244-252.
  • Miramond, T., E. Aguado, et al. (2013). In vivo comparative study of two injectable/moldable calcium phosphate bioceramics. Key Engineering Materials, Trans Tech Publications.
  • Miramond, T., P. Borget, et al. (2013). Composite bioceramics/polymer electrospun scaffolds for regenerative medicine. Key Engineering Materials, Trans Tech Publications.
  • Naji, A., N. Rouas‐Freiss, et al. (2013). “Concise review: combining human leukocyte antigen G and mesenchymal stem cells for immunosuppressant biotherapy.” Stem Cells 31(11): 2296-2303.
  • Prel, A., L. Sensébé, et al. (2013). “Influence of untranslated regions on retroviral mRNA transfer and expression.” BMC biotechnology 13(1): 35.
  • Ragni, E., T. Montemurro, et al. (2013). “Differential microRNA signature of human mesenchymal stem cells from different sources reveals an “environmental-niche memory” for bone marrow stem cells.” Experimental cell research 319(10): 1562-1574.
  • Ragni, E., M. Viganò, et al. (2013). “Adipogenic potential in human mesenchymal stem cells strictly depends on adult or foetal tissue harvest.” The international journal of biochemistry & cell biology 45(11): 2456-2466.
  • Ragni, E., M. Vigano, et al. (2013). “What is beyond a qRT‐PCR study on mesenchymal stem cell differentiation properties: how to choose the most reliable housekeeping genes.” Journal of cellular and molecular medicine 17(1): 168-180.
  • Sensebé, L. and S. Fleury-Cappellesso (2013). “Biodistribution of mesenchymal stem/stromal cells in a preclinical setting.” Stem cells international 2013.
  • Sensebé, L., M. Gadelorge, et al. (2013). “Production of mesenchymal stromal/stem cells according to good manufacturing practices.”
  • Sensebé, L., M. Gadelorge, et al. (2013). “Production of mesenchymal stromal/stem cells according to good manufacturing practices: a review.” Stem cell research & therapy 4(3): 66.
  • Seris, E., P. Borget, et al. (2013). “Bone regeneration at the expense of Bioceramic/Hydrogel composite: Clinical evidence.” IRBM 34(4): 342-345.
  • Varin, A., C. Pontikoglou, et al. (2013). “CD200R/CD200 inhibits osteoclastogenesis: new mechanism of osteoclast control by mesenchymal stem cells in human.” PLoS One 8(8): e72831.
  • Veronesi, E., A. Murgia, et al. (2013). “Transportation conditions for prompt use of ex vivo expanded and freshly harvested clinical-grade bone marrow mesenchymal stromal/stem cells for bone regeneration.” Tissue Engineering Part C: Methods 20(3): 239-251.
  • Alexandrino, E. M., S. Ritz, et al. (2014). “Paclitaxel-loaded polyphosphate nanoparticles: a potential strategy for bone cancer treatment.” Journal of Materials Chemistry B 2(10): 1298-1306.
  • Bassi, G., F. Guilloton, et al. (2014). “Effects of a ceramic biomaterial on immune modulatory properties and differentiation potential of human mesenchymal stromal cells of different origin.” Tissue Engineering Part A 21(3-4): 767-781.
  • Bassi, G., F. Guilloton, et al. (2014). “Effects of a novel ceramic biomaterial on immune modulatory properties and differentiation potential of mesenchymal stromal cells.” Cytotherapy 16(4): S90-S91.
  • M.Á. Brennan, A. Renaud, J. Amiaud, M.T. Rojewski, H. Schrezenmeier, D. Heymann, V. Trichet, P. Layrolle. Pre-clinical studies of bone regeneration with human bone marrow stromal cells and biphasic calcium phosphate. Stem Cell Res. Ther., 5 (5) (2014), p. 114 PDF
  • Bouderlique, T., E. Henault, et al. (2014). “Pleiotrophin commits human bone marrow mesenchymal stromal cells towards hypertrophy during chondrogenesis.” PLoS One 9(2): e88287.
  • Canal, C., S. Gallinetti, et al. (2014). “Low‐Pressure Plasma Treatment of Polylactide Fibers for Enhanced Mechanical Performance of Fiber‐Reinforced Calcium Phosphate Cements.” Plasma Processes and Polymers 11(7): 694-703.
  • Daculsi, G., B. H. Fellah, et al. (2014). The essential role of calcium phosphate bioceramics in bone regeneration. Advances in Calcium Phosphate Biomaterials, Springer Berlin Heidelberg: 71-96.
  • Di Trapani, M., G. Bassi, et al. (2014). “Immune regulatory properties of CD117pos amniotic fluid stem cells vary according to gestational age.” Stem cells and development 24(1): 132-143.
  • Gallinetti, S., C. Canal, et al. (2014). “Development and Characterization of Biphasic Hydroxyapatite/β‐TCP Cements.” Journal of the American Ceramic Society 97(4): 1065-1073.
  • Gamblin, A. L., A. Renaud, et al. (2014). “Osteoblastic and osteoclastic differentiation of human mesenchymal stem cells and monocytes in a miniaturized three-dimensional culture with mineral granules.” Acta biomaterialia 10(12): 5139-5147.
  • Gamblin, A.-L., M. A. Brennan, et al. (2014). “Bone tissue formation with human mesenchymal stem cells and biphasic calcium phosphate ceramics: the local implication of osteoclasts and macrophages.” Biomaterials 35(36): 9660-9667.
  • Gómez-Barrena, E., C. A. Solá, et al. (2014). “Regulatory authorities and orthopaedic clinical trials on expanded mesenchymal stem cells.” International orthopaedics 38(9): 1803-1809.
  • Miramond, T., P. Borget, et al. (2014). Comparative critical study of commercial calcium phosphate bone substitutes in terms of physic-chemical properties. Key Engineering Materials, Trans Tech Publications.
  • Miramond, T., P. Corre, et al. (2014). Osteoinduction and osteopromotion of smart biphasic calcium phosphate scaffolds MBCP (R): in vivo proof of concept. Journal of tissue engineering and regenerative medicine, WILEY-BLACKWELL 111 RIVER ST, HOBOKEN 07030-5774, NJ USA.
  • Miramond, T., P. Corre, et al. (2014). “Osteoinduction of biphasic calcium phosphate scaffolds in a nude mouse model.” Journal of biomaterials applications 29(4): 595-604.
  • Montespan, F., F. Deschaseaux, et al. (2014). “Osteodifferentiated mesenchymal stem cells from bone marrow and adipose tissue express HLA-G and display immunomodulatory properties in HLA-mismatched settings: implications in bone repair therapy.” Journal of immunology research 2014.
  • Pećina, M. and S. Vukičević (2014). Tissue engineering and regenerative orthopaedics (TERO), Springer Berlin Heidelberg.
  • Rosset, P., F. Deschaseaux, et al. (2014). “Cell therapy for bone repair.” Orthopaedics & Traumatology: Surgery & Research 100(1): S107-S112.
  • Rosso, L., V. Parazzi, et al. (2014). “Pleural tissue repair with cord blood platelet gel.” Blood Transfusion 12(Suppl 1): s235.
  • SILIBILIN, B. O. (2014). “SEFC 2014. ORAL COMUNICATIONS SECTION: CLINICAL TRIALS.” Basic & Clinical Pharmacology & Toxicology 115(3): 12-19.
  • Brennan, M. Á., A. Renaud, et al. (2015). “3D cell culture and osteogenic differentiation of human bone marrow stromal cells plated onto jet-sprayed or electrospun micro-fiber scaffolds.” Biomedical Materials 10(4): 045019.
  • Daculsi, G. (2015). “Smart scaffolds: the future of bioceramic.” Journal of Materials Science: Materials in Medicine 26(4): 1-4.
  • Gómez-Barrena, E., P. Rosset, et al. (2015). “Bone fracture healing: cell therapy in delayed unions and nonunions.” Bone 70: 93-101.
  • Lebouvier A, Poignard A, Cavet M, Amiaud J, Leotot J, Hernigou P, Rahmouni A, Bierling P, Layrolle P, Rouard H, Chevallier N (2015) Development of a simple procedure for the treatment of femoral head osteonecrosis with intra-osseous injection of bone marrow mesenchymal stromal cells: study of their biodistribution in the early time points after injection. Stem Cell Res Ther 6:68. PDF
  • Miramond, T., T. Rouillon, et al. (2015). Biphasic calcium phosphate: preferential ionic substitutions and crystallographic relationships at grain boundaries. Key Engineering Materials, Trans Tech Publications.
  • Petrella, F., F. Acocella, et al. (2015). “Airway fistula closure after stem-cell infusion.” New England Journal of Medicine 372(1): 96-97.
  • Veronesi, E., J. S. Burns, et al. (2015). “cGMP-Compliant Transportation Conditions for a Prompt Therapeutic Use of Marrow Mesenchymal Stromal/Stem Cells.” Stem Cells and Good Manufacturing Practices: Methods, Protocols, and Regulations: 109-122. PDF
  • Wuchter, P., K. Bieback, et al. (2015). “Standardization of Good Manufacturing Practice–compliant production of bone marrow–derived human mesenchymal stromal cells for immunotherapeutic applications.” Cytotherapy 17(2): 128-139
  • Daculsi, G., E. Aguado, et al. (2016). “Essential Requirements for Resorbable Bioceramic Development: Research, Manufacturing, and Preclinical Studies.” Handbook of Bioceramics and Biocomposites: 471-501.
  • Murgia, A., E. Veronesi, et al. (2016). “Potency Biomarker Signature Genes from Multiparametric Osteogenesis Assays: Will cGMP Human Bone Marrow Mesenchymal Stromal Cells Make Bone?” PLoS One 11(10): e0163629.
  • Pontikoglou, C., A. Langonné, et al. (2016). “CD200 expression in human cultured bone marrow mesenchymal stem cells is induced by pro‐osteogenic and pro‐inflammatory cues.” Journal of cellular and molecular medicine.
  • Rapp, A. E., R. Bindl, et al. (2016). “Fracture Healing Is Delayed in Immunodeficient NOD/scid‑ IL2Rγ c null Mice.” PLoS One 11(2): e0147465.
  • Stanovici, J., L.-R. Le Nail, et al. (2016). “Bone regeneration strategies with bone marrow stromal cells in orthopaedic surgery.” Current Research in Translational Medicine 64(2): 83-90.